KLEMP WALTER V bought MBRX
August 3, 2026 · Form 4 insider transaction
KLEMP WALTER V bought 533,333 shares of Moleculin Biotech, Inc., a transaction worth N/A. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
533,333
Price
N/A
Total value
N/A
InsiderKLEMP WALTER V
Role—
SecurityCommon Stock
Transaction codeP: Open-market purchase
Transaction dateAugust 3, 2026
Filing dateAugust 5, 2026
Shares owned after564,340
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
On August 3, 2026, the reporting person acquired 533,333 shares of common stock and Series I warrants to purchase 1,599,999 shares of common stock at a combined purchase price of $0.75 per one share of common stock and three accompanying warrants in a public offering.